Label Value
DOI 10.1186/s12872-016-0364-6
TITLE Rationale and design of the Children’s Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure
TYPE article
Service Status Date Last Checked
Scopus Yes 2017-01-11T17:52:35.421349+00:00
Web of Science Yes 2018-04-08T19:58:33.434744
Compendex No 2020-12-23T15:51:01.684471